Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients

Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients

Previous studies showed that monoclonal immunoglobulins G (IgGs) of “monoclonal gammopathy of undetermined significance” (MGUS) and myeloma were hyposialylated, thus presumably pro-inflammatory, and for about half of patients, the target of the monoclonal IgG was either a virus—Epstein–Barr virus (E...

Full description

Bibliographic Details
Main Authors:	Adrien Bosseboeuf, Célia Seillier, Nicolas Mennesson, Sophie Allain-Maillet, Maeva Fourny, Anne Tallet, Eric Piver, Philippe Lehours, Francis Mégraud, Laureline Berthelot, Jean Harb, Edith Bigot-Corbel, Sylvie Hermouet
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-05-01
Series:	Frontiers in Immunology
Subjects:	monoclonal immunoglobulin A (IgA) multiple myeloma monoclonal gammopathy of undetermined significance (MGUS) infectious antigens Epstein–Barr virus hepatitis C virus
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.00854/full

Similar Items

Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1
by: Adrien Bosseboeuf, et al.
Published: (2020-05-01)

Determination of the target of monoclonal immunoglobulins: a novel diagnostic tool for individualized MGUS therapy, and prevention and therapy of smoldering and multiple myeloma
by: Sylvie Hermouet, et al.
Published: (2023-10-01)

Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens
by: Jean Harb, et al.
Published: (2021-02-01)

Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins
by: Adrien Bosseboeuf, et al.
Published: (2017-10-01)

Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma
by: Alba Rodríguez-García, et al.
Published: (2022-01-01)

The “Undetermined Significance” of <sup>18</sup>F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
by: Giorgio Treglia, et al.
Published: (2021-08-01)

Ulcerating necrobiotic xanthogranuloma: A clinical sign to reconsider progression from MGUS to multiple myeloma
by: Christopher J. Fay, BA, et al.
Published: (2023-10-01)

Editorial: The Role of Microorganisms in Multiple Myeloma
by: Maria Linares, et al.
Published: (2022-06-01)

A gene signature can predict risk of MGUS progressing to multiple myeloma
by: Fumou Sun, et al.
Published: (2023-06-01)

Increased monoclonal components: Prevalence in an Italian population of 44 474 outpatients detected by capillary electrophoresis
by: Vernocchi Arialdo, et al.
Published: (2016-01-01)

Editorial: Structure, Isotypes, Targets, and Post-translational Modifications of Immunoglobulins and Their Role in Infection, Inflammation and Autoimmunity
by: Jean Harb, et al.
Published: (2020-08-01)

Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment
by: Artem Oganesyan, et al.
Published: (2022-11-01)

A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow‐up
by: Larry D. Anderson Jr., et al.
Published: (2024-02-01)

Oral, periorbital, and inguinal purpura in a patient with paraproteinemia
by: Donn LaTour, BS, et al.
Published: (2022-09-01)

Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism
by: Shahrzad Jalali, et al.
Published: (2021-05-01)

Renal Disorders Associated with Waldenström Macroglobulinaemia, IgM MGUS and IgM-Producing B-Cell Lymphoproliferative Disorders
by: Guy Pratt, et al.
Published: (2023-06-01)

Pulmonary nodules associated with pulmonary embolism: A rare and misleading presentation of amyloidosis
by: Trescos Florent, et al.
Published: (2020-01-01)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
by: Oliver C. Lomas, et al.
Published: (2020-06-01)

Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies
by: Johannes P. M. van de Mortel, et al.
Published: (2022-10-01)

Accuracy and Reliability of Internet Resources for Information on Monoclonal Gammopathy of Undetermined Significance—What Information Is out There for Our Patients?
by: Emma Pauline Kreutzer, et al.
Published: (2021-09-01)

Coexistence of scleromyxedema and Sneddon syndrome
by: Antonio Furci, MD, et al.
Published: (2021-05-01)

Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma
by: Andrea Knight, et al.
Published: (2021-08-01)

B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS
by: Kristin Schmidt, et al.
Published: (2020-12-01)

Unusual Manifestations of Monoclonal Gammopathy: I. Ocular Disease
by: Sophia R. Balderman, et al.
Published: (2015-07-01)

DPO multiplex PCR as an alternative to culture and susceptibility testing to detect <it>Helicobacter pylori </it>and its resistance to clarithromycin
by: Siffré Elodie, et al.
Published: (2011-10-01)

Localization of the antigenic sites of Newcastle disease virus nucleocapsid using a panel of monoclonal antibodies
by: Ahmad-Raus, Raha, et al.
Published: (2009)

Immunological Detection of Newcastle Disease Viral Antigen in the Naturally Infected Chickens by Monoclonal Antibodies against Fusion-2 Protein
by: Nyoman Mantik Astawa, et al.
Published: (2014-08-01)

Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection
by: Olivier Tshiani Mbaya, et al.
Published: (2021-08-01)

Hematological Diseases and Osteoporosis
by: Agostino Gaudio, et al.
Published: (2020-05-01)

Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases
by: Lukas J. Schnitzler, et al.
Published: (2017-05-01)

Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms
by: Sophie Allain-Maillet, et al.
Published: (2020-08-01)

Identifying monoclonal gammopathy of undetermined significance from electronic health records
by: Hilary C. Tanenbaum, et al.
Published: (2023-03-01)

Detection of Parechovirus A1 with Monoclonal Antibody against Capsid Protein VP0
by: Ming-Hsiang Kung, et al.
Published: (2020-11-01)

Monoclonal Antibodies for COVID-19 Treatment: Is It an Option in Indonesia?
by: Alvina Widhani
Published: (2023-07-01)

Ebola drug trial: a ray of hope
by: Shobanbabu Varthya, et al.
Published: (2019-12-01)

Editorial: Structure, isotypes, targets, and post-translational modifications of immunoglobulins and their role in infection, inflammation and autoimmunity, Volume II
by: Jan Novak, et al.
Published: (2022-10-01)

Mass Cytometry Discovers Two Discrete Subsets of CD39−Treg Which Discriminate MGUS From Multiple Myeloma
by: Felix Marsh-Wakefield, et al.
Published: (2019-08-01)

Concomitant transformation to multiple myeloma and acute biphenotypic leukemia from MGUS simultaneously diagnosed with essential thrombocythemia 37-years before.
by: Pasquale Niscola
Published: (2014-08-01)

Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports
by: Simona Elba, et al.
Published: (2020-06-01)

Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners
by: Charlene M. McShane, et al.
Published: (2019-05-01)